Calf Augmentation in China
Calf Augmentation in China section, includes general infrmation about Calf Augmentation Procedure, Calf Augmentation China Local News, Calf Augmentation China Surgeon Locator and other Calf Augmentation related material.
Calf Augmentation Procedure
This procedure offers a solution for those people that have underdeveloped calves or wish to augment them. The idea is to shape and size the calves by surgical insertion of implants. The implants are made of soft silicon and they come in different shapes and sizes. Before the operation your legs will be measured to select a proper implant for your needs. There is an alternative to implants. Calf augmentation can also be performed by liposuction of fat from other body parts and injecting it into the calves. This method is not suitable for people with no extra fat to be removed. Another problem is fat absorption that eventually occurs, sometimes creating not symmetric calves. Men and women can benefit from this procedure. Men usually want to increase the muscle bulk, giving them more masculine look and women wish to get more symmetrical appearance of their legs. This procedure also may help to correct some congenital defects, those include polio, spina bifida and clubfoot, all this conditions may be associated with undeveloped calves.
This procedure can be done with local or general anesthesia, and it usually lasts for an hour. During the operation the patient is laying on their back. A cut is made in the concavity behind the knee, then the skin is gently separated and a space is created. The implant is inserted above the muscles. After one leg is done the doctor performs the same on the other one. After the symmetry is confirmed the surgeon closes the cuts with stitches.
Every operation has its ricks. This one includes bleeding, infection and sometimes implants shrinkage and asymmetry.
After the surgery you may feel some degree of pain. Your doctor'll subscribe you for painkillers. At the first two days you'll be asked to raise your legs whenever you are sitting, this to reduce swelling. Afterwards, the bandages are removed and you are encouraged to walk more intensively to train your calve muscles. For about two weeks you'll fell like you're calves is been through excessive workout. Swelling and bruising also may appear, they are only temporary and will improve with time. You'll be able to go back to work after 7-10 days. You'll get detailed instructions from you're surgeon regarding the activities you should avoid, for example long walking, weight lifting and running. Usually, most of the patients are able to return to their daily activities after 4-6 weeks.
Other Calf Augmentation Procedures
All Body Procedures
Calf Augmentation China (current)
Calf Augmentation China Buttock Augmentation
Calf Augmentation China Bariatric surgery
Calf Augmentation China Liposuction
Calf Augmentation China Body Contouring
More China info...
China Other destinations Some of the most famous tourist attractions in China are:
Great Wall of China
Tibet
Silk Road
Hainan island, tropical paradise China has dozens of UNESCO World Heritage sites.
China People China is a very diverse place with large variations in culture, language, customs, and economic levels. The economic landscape is particularly diverse. The major cities such as Beijing, Guangzhou and Shanghai are rich and modern. However, more than half the population, some 800 million rural residents, still live as peasants, farming with manual labour or draft animals. Many of these men and women live in severe poverty. A Chinese government estimate [1] as of 2005 had 90 million living on under ¥ 924 ($112 US) a year; 26 million were under the official poverty line, ¥ 668 ($81 US) a year.
Plastic Surgery News...
- This review examines the evidence on rivaroxaban (Xarelto®), an oral, direct factor Xa inhibitor for the prevention of venous thromboembolism (VTE) in patients undergoing major orthopaedic surgery of the lower limbs. A licence application was submitted to the EMEA in November 2007.
The review notes that limited data from the phase III RECORD studies (available in abstract form only) suggest that:
• Daily oral rivaroxaban 10mg is statistically significantly more effective than subcutaneous (s.c.) enoxaparin 40mg for short term thromboprophylaxis in patients undergoing total knee replacement; the primary endpoint (composite of DVT, non-fatal PE , and all-cause mortality) occurred in 9.6% and 18.9% of patients assigned to rivaroxaban or enoxaparin, respectively (p < 0.001).
• In extended thromboprophylaxis for hip arthroplasty, the same primary endpoint was achieved in 1.1% of rivaroxaban patients vs. 3.7% of those receiving enoxaparin (p < 0.001).
• Rivaroxaban and enoxaparin recipients experienced a similar incidence of major bleeding events, ranging from 0.1% to 0.6%.
No phase III liver function test data are available, but phase II data suggest that increases in liver enzymes seen in rivaroxaban recipients were of a similar order to enoxaparin recipients after 5–9 days of treatment. However caution is required until further information is available regarding safety. The review concludes “should efficacy and safety data prove favourable for oral rivoroxaban, and depending on cost, the drug might be particularly appropriate for those patients undergoing extended thromboprophylaxis after hip surgery. There will be no necessity to monitor patients for heparin-induced thrombocytopenia and a reduction in at home nurse visits may be possible. Hence, staff capacity may be released. Economic decisions concerning rivaroxaban uptake will need to balance the possible increase in drug costs versus the possible benefits that may accrue.”
- The biotechnology industry, which for years has opposed bills that would allow FDA to approve generic versions of biotech medications, has made such legislation a priority for 2008, the AP/Raleigh News & Observer reports.